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What interventions 
reduce the risk 
of contrast nephropathy
for high-risk patients?
■ Evidence-Based Answer
Several interventions may reduce the risk of con-
trast nephropathy for high-risk patients; however,
most evidence uses surrogate markers for clinical-
ly relevant outcomes. Because dehydration is a risk
factor for developing contrast nephropathy,
periprocedural hydration is routinely recommend-
ed (strength of recommendation [SOR]: C, expert
opinion). Single studies have suggested that isoton-
ic saline is associated with less risk than half-nor-
mal saline, and hydration with fluids containing
sodium bicarbonate is more efficacious than those
containing isotonic saline (SOR: B, single random-
ized controlled trial [RCT]). 
Oral acetylcysteine lowers the risk of post-
contrast elevations in creatinine if taken more than
24 hours before contrast administration (SOR: A,
RCTs). Acetylcysteine’s low cost and favorable side
effect profile make it an appealing option. Hypo-
osmolar contrast media are less likely to induce con-
trast nephropathy than hyper-osmolar media (SOR:
A, RCTs). Finally, hemofiltration might be consid-
ered for patients with extremely high risk of devel-
oping contrast nephropathy (SOR: B, single RCT).
■ Evidence Summary
Intravascular administration of radiocontrast is
frequently associated with acute reductions in
renal function, particularly for patients with risk
factors (TABLE 1). Most studies have used opera-
tional definitions of contrast nephropathy based
on predefined elevations in serum creatinine from
baseline, the great majority of which are transient
and clinically insignificant. It is unclear if interven-
tions that reduce the rate of mild creatinine eleva-
tions (TABLE 2) also reduce the risk of clinically
relevant adverse outcomes. 
A single RCT showed decreased risk of con-
trast nephropathy for patients pretreated with
intravenous fluids containing sodium bicarbonate
compared with those pretreated with a sodium
chloride solution (number needed to treat
[NNT]=8.4).2 Another RCT showed that peripro-
cedural hydration with isotonic saline is superior
to half-normal saline in preventing contrast
nephropathy (NNT=77).3 Several studies have
demonstrated decreased risk of contrast nephropa-
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thy for high-risk patients when low-osmolality
contrast media are used rather than high-
osmolality contrast media (NNT=27).4 A single
study suggested that iso-osmolar contrast media
generate less contrast induced nephropathy than
low-osmolar contrast media.5 Because the primary
outcome in these studies was a change in serum
creatinine, the NNTs listed above may not predict
clinical outcomes. 
Periprocedural administration of acetylcys-
teine reduces the risk of contrast nephropathy in
high-risk patients (odds ratio=0.56; 95% confi-
dence interval, 0.37–0.84). Oral acetylcysteine is
effective if intervention is begun 24 hours before
contrast administration.6 Preliminary evidence
shows that intravenous administration of acetyl-
cysteine immediately before contrast administra-
tion lowers the risk of contrast nephropathy.7
Oral acetylcysteine is low in cost and has no
known side effects. 
A single RCT suggests that hemofiltration ini-
tiated 4 to 6 hours before contrast administration
reduces the incidence of contrast nephropathy
among high-risk patients.8 The study was unusual
in that patients in the intervention group experi-
enced statistically significant reductions in several
clinically relevant outcomes, including in-hospital
mortality and cumulative 1-year mortality (in-
hospital mortality, NNT=8.3; cumulative 1-year
mortality, NNT=5). Hemofiltration is expensive
and is not available in many institutions.
■ Recommendations from Others
The American College of Radiology recommends
using low-osmolality contrast media for patients
with renal insufficiency, particularly those with 
diabetes.9 Clinical Evidence found support for the
use of low-osmolality contrast media, periproce-
dural hydration, and acetylcysteine as interventions
to reduce the risk of contrast nephropathy.10
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T A B L E 1
Advanced age
Diabetes mellitus
Chronic renal insufficiency
Congestive heart failure
Acute myocardial infarction
Cardiogenic shock
Renal transplant
Hemodynamic instability
Dehydration
Low serum albumin
Angiotensin-converting enzyme use
Nonsteroidal anti-inflammatory drug use
Furosemide use
Higher volume of contrast media
Source: Nikolsky et al, Rev Cardiovasc Med 2003.1
Risk factors for the development 
of contrast nephropathy
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T A B L E 2
INTERVENTION SOR PROTOCOLS
Acetylcysteine (oral) A Acetylcysteine 600 mg PO twice daily is generally given for 2 days
beginning on the day prior to the procedure.6
Hypo-osmolar contrast media A A variety of protocols have been demonstrated to be effective. 4
Acetylcysteine B 150 mg/kg of acetylcysteine was given in 500 mL of 
(IV) normal saline over 30 min immediately before contrast followed 
by 50 mg/kg of acetylcysteine in 500 mL of normal saline over 4 h. 7
Iso-osmolar contast media B Varying volumes of iodixanol, an iso-osmolar contrast medium,
were used rather than iohexol, a low osmolar contrast medium.5
Sodium bicarbonate B Patients were given 4.23% dextrose in H20 with 154 mEq of sodi-
um bicarbonate added per liter. Fluids were begun 1 hour prior 
to contrast administration running at 3 mL/kg/hr for 1 hour and
then at 1 mL/kg/hr until 6 hours after contrast administration.2
Isotonic saline B 0.9% sodium chloride was run at 1 mL/kg/hr beginning at 8 a.m. 
on the morning of the procedure or as early as possible prior to
emergency procedures. The infusion was discontinued at 8 a.m. 
on the morning following the procedure.3
Hemofiltration B Hemofiltration was started 4 to 6 hours before the procedure. It
was resumed after the procedure was completed and continued
for 18 to 24 hours.8
SOR, strength of recommendation. (For more on evidence ratings, see “Evidence-based medicine terms” on page 381.
Interventions to reduce risk of contrast nephropathy
■ Clinical Commentary
Avoid radiocontrast agents when possible;
consider hydration and acetylcysteine 
The best prevention of contrast nephropathy 
is to avoid radiocontrast agents whenever pos-
sible. Ultrasound, MRI, or CT scanning without
radiocontrast can often provide adequate infor-
mation. However, when contrast agents must
be used for high-risk patients, lower doses and
iso-osmolal nonionic agents should be consid-
ered, and serial studies should be spaced out.
Adequate hydration and avoidance of drugs
with renal effects, including nonsteroidal anti-
inflammatory drugs, diuretics, and angiotensin-
converting enzyme inhibitors, can decrease the
risk of contrast nephropathy for patients requir-
ing a contrast study. Patients can be hydrated
and their medicines held starting the day before
the procedure. For patients with any risk factors
for contrast nephropathy, acetylcysteine should
also be administered. Sodium bicarbonate can
also lower the risk of nephropathy by adminis-
tering it at the time of the procedure.
Contrast nephropathy has often been defined
as an immediate increase in creatinine greater
than 25%. The clinical significance of small tran-
sient elevations in creatinine is unclear.
Furthermore, the wide variability reported in the
incidence of contrast nephropathy results from
differences in the presence of risk factors.
Therefore, it is important to assess each patient’s
risk individually and undertake additional preven-
tive measures accordingly.
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